5Granger J, Remick D. Acute pancreatitis: models, markers, and mediators[J]. Shock, 2005, 24( 1 ) :45 -51. 被引量：1
6Chen CC, Wang SS, Lu RH, et al. Early changes of serum proinflammatory and anti-inflammatory cytokines after endoscopic retrograde cholangiopancreatography[J]. Pancreas, 2003, 26 ( 4 ) : 375 - 380. 被引量：1
7Andriulli A, Leandro G, Niro G, et al. Pharmacologic treatment can prevent pancreatic injury after ERCP: a meta-analysis [ J ]. Gastrointest Endosc, 2000, 51 ( 1 ) : 1 - 7. 被引量：1
8Andriulli A, Clemente R, Sohni L, et al. Gabexate or somatostatin administration before ERCP in patients at high risk for post-ERCP pancreatitis: a muhicenter, placebo-controlled, randomized clinical trial[J]. Gastrointest Endose, 2002, 56(4) :488 -495. 被引量：1
9Arvanitidis D, Anagnostopoulos GK, Giannopoulos D, et al. Can somatostatin prevent post-ERCP pancreatitis? Results of a randomized eontrolled trial [ J ]. J Gastroenterol Hepatol, 2004, 19 ( 3 ) : 278 - 282. 被引量：1
10Murray B, Carter R, Imrie C, et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography [ J ]. Gastroenterology, 2003, 124 (7) : 1786 - 1791. 被引量：1
